Rivaroxaban in Clinical Practice for Atrial Fibrillation With Special Reference to Prothrombin Time

Circulation Journal - Japan
doi 10.1253/circj.cj-13-1380
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Role of Rivaroxaban in the Management of Atrial Fibrillation: Insights From Clinical Practice

Vascular Health and Risk Management
2018English

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2014English

Rivaroxaban Precision Dosing Strategy for Real World Atrial Fibrillation Patients

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2020English

Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2015English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

ABC of Atrial Fibrillation: ATRIAL FIBRILLATION IN GENERAL AND HOSPITAL PRACTICE

BMJ
1996English

Health Economic Evaluation of Rivaroxaban in Elective Cardioversion of Atrial Fibrillation

European Journal of Health Economics
Health PolicyEconomicsEconometricsFinance
2017English

Atrial Fibrillation and Stroke Risk Prevention in Real-Life Clinical Practice

Thrombosis and Haemostasis
Hematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy